ReviewMicroorganisms2023

Efficacy and Safety of Two-Drug Regimens That Are Approved from 2018 to 2022 for the Treatment of Human Immunodeficiency Virus (HIV) Disease and Its Opportunistic Infections.

Palanisamy Sivanandy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.